首页> 美国卫生研究院文献>The Oncologist >A Prospective Controlled Study of the Botanical Compound Mixture LCS101 for Chemotherapy-Induced Hematological Complications in Breast Cancer

【2h】

A Prospective Controlled Study of the Botanical Compound Mixture LCS101 for Chemotherapy-Induced Hematological Complications in Breast Cancer

机译：植物复合混合物LCS101对乳腺癌化疗引起的血液学并发症的前瞻性对照研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background.This prospective, controlled study evaluated the safety, tolerability, and efficacy of the mixture of botanical compounds known as LCS101 in preventing chemotherapy-induced hematological toxicity in breast cancer patients.

机译：背景：这项前瞻性，对照研究评估了称为LCS101的植物性化合物混合物在预防乳腺癌患者化疗引起的血液学毒性方面的安全性，耐受性和功效。

著录项

期刊名称 The Oncologist
作者
Neora Yaal-Hahoshen; Yair Maimon; Nava Siegelmann-Danieli; Shahar Lev-Ari; Ilan G. Ron; Fani Sperber; Noah Samuels; Jacob Shoham; Ofer Merimsky;
展开▼
作者单位

展开▼
年(卷),期 2011(16),9
年度 2011
页码 1197–1202
总页数 6
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词
Breast cancer Chemotherapy Hematological toxicity Prevention Botanical compounds;

机译：乳腺癌;化学疗法;血液毒性;预防;植物性化合物;

相似文献

外文文献
中文文献
专利

1. Letter to the editor regarding "A prospective, controlled study of the botanical compound mixture LCS101 for chemotherapy-induced hematological complications in breast cancer" by Yaal-Hahoshen et al. (The Oncologist 2011;16:1197-1202) [J] . MooimanK.D., GoeyA.K.L., MeijermanI., The oncologist . 2012,第5期

机译：Yaal-Hahoshen等人写给编辑的信，内容涉及“植物性化合物混合物LCS101用于化学疗法诱发的乳腺癌血液并发症的前瞻性对照研究”。（肿瘤学家2011; 16：1197-1202）
2. Re: Letter to the editor regarding "A prospective, controlled study of the botanical compound mixture LCS101 for chemotherapy-induced hematological complications in breast cancer" by Yaal-Hahoshen et al. (The Oncologist 2011;16:1197-1202) [J] . SamuelsN., MaimonY., Siegelmann-DanieliN. The oncologist . 2012,第5期

机译：回复：作者Yaal-Hahoshen等人写信给编辑，内容为“针对化学疗法诱发的乳腺癌血液并发症的植物性化合物LCS101的前瞻性对照研究”。（肿瘤学家2011; 16：1197-1202）
3. A prospective, controlled study of the botanical compound mixture LCS101 for chemotherapy-induced hematological complications in breast cancer. [J] . Yaal Hahoshen N, Maimon Y, Siegelmann Danieli N, The oncologist . 2011,第9期

机译：植物性化合物混合物LCS101在化学疗法诱发的乳腺癌血液并发症中的前瞻性对照研究。
4. Airborne Dioxin Exposure and Breast Cancer Risk in a Case-Control Study Nested within the French E3N Prospective Cohort [C] . Aurelie Danjou, Thomas Coudon, Delphine Praud, Joint annual meeting of the International Society of Exposure Science and the International Society for Environmental Epidemiology . 2018

机译：嵌套在法国E3N前瞻性队列中的病例对照研究中，空气中二恶英暴露与乳腺癌风险
5. Breast cancer risk and environmental factors—tobacco smoke and cooking fumes: A prospective cohort study of Shanghai women [D] . Zhu, Honghong 2007

机译：乳腺癌风险和环境因素—吸烟和吸烟：上海女性的前瞻性队列研究
6. Letter to the Editor Regarding A Prospective Controlled Study of the Botanical Compound Mixture LCS101 for Chemotherapy-Induced Hematological Complications in Breast Cancer by Yaal-Hahoshen et al. (The Oncologist 2011;16:1197–1202) [O] . Kim D. Mooiman, Andrew K.L. Goey, Irma Meijerman, 2012

机译：Yaal-Hahoshen等人就化学疗法诱发乳腺癌血液并发症的植物性化合物LCS101的前瞻性对照研究致编辑信。（The Oncologist 2011; 16：1197–1202）
7. Effect of the Botanical Compound LCS101 on Chemotherapy-Induced Symptoms in Patients with Breast Cancer: A Case Series Report [O] . Noah Samuels, Yair Maimon, Rachel Y. Zisk-Rony 2013

机译：植物化合物LCs101对乳腺癌患者化疗诱发症状的影响：病例系列报告

A Prospective Controlled Study of the Botanical Compound Mixture LCS101 for Chemotherapy-Induced Hematological Complications in Breast Cancer

摘要

著录项

相似文献

相关主题

期刊订阅